0001187953 2026-07-22 2026-07-22 0001187953 1 2026-07-22 2026-07-22 0001187953 1 2026-07-22 2026-07-22 0001187953 2 2026-07-22 2026-07-22 iso4217:USD pure N/A EX-FILING FEES S-3 0001187953 Creative Medical Technology Holdings, Inc. S-3 false Equity Common stock, par value $0.001 per share true 5580680 0.88 4910998.4 0.0001381 678.21 4910998.4 678.21 678.21 0 <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(2)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Estimated solely for the purpose of calculation of the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $0.88, the average of the high and low reported sales prices of the registrant’s common stock on the NASDAQ Capital Market on July 17, 2026.</p></td></tr></tbody></table> true true Creative Medical Technology Holdings, Inc S-1 333-297026 2026-06-25 678.21 Equity Common Stock and Warrants false Creative Medical Technology Holdings, Inc. S-1 333-297026 2026-06-25 678.21 <p style="font-size:10pt;font-family:times new roman;margin:0px">Creative Medical Technology Holdings, Inc. (the “Registrant”) previously filed a registration statement on Form S-1 (File No. 333-297026), initially filed on June 25, 2026 (the “Prior Registration Statement”), which registered $6,000,000 of Common Stock and $12,000,000 of Common Stock issuable upon exercise of warrants for a proposed maximum aggregate offering price of $18,000,000.  As a result, the Registrant has $2,485.80 in unused filing fees associated with the Prior Registration Statement. In accordance with Rule 457(p) under the Securities Act, the registrant is using $678.21 of the unused filing fees to offset the filing fee payable in connection with this filing. The Registrant has terminated the offering that included the unsold securities under the Prior Registration Statement.</p> true